Notably, the currently marketed GLP-1RAs, such as Semaglutide, Liraglutide, and Lixisenatide, are long-chain GLP-1 mimetic peptides, ranging in length from 33 to 39 amino acids
It is often used as a supplement to manage conditions such as heart disease, kidney disease, and muscle disorders
In justified circumstances (in which the benefits outweigh the risks), nicotinic acid may be considered in order to reduce residual risk in patients with high Lp(a) concentration if other agents (i.e., PCSK9 inhibitors or inclisiran) are not available
Weight reduction should be gradual (0.51 kg weekly) to avoid rapid mobilisation of fat, which paradoxically may worsen liver inflammation
S2CID 23663167
A structural protein found in skin, hair, nails, and connective tissues